PMN — Promis Neurosciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro Cap

Annual balance sheet for Promis Neurosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2018 December 31st	2019 December 31st	2020 December 31st	R2021 December 31st	2022 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	Interim Report	ARS
Standards:	IFRS	IFRS	IFRS	USG	USG
Status:	fx Final	fx Final	fx Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	1.78	1.31	0.841	17	5.91
Net Total Accounts Receivable
Net Total Receivables	0.04	0.057	0.031	—	—
Prepaid Expenses
Total Current Assets	2.13	1.56	0.975	17.7	6.9
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.001	0	0.078	0.005	0
Net Intangible Assets
Long Term Investments
Total Assets	2.17	1.6	1.09	17.7	6.92
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	1.33	1.29	1.89	0.929	6.41
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	1.33	1.29	1.89	12.1	8.27
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	0.848	0.307	-0.798	5.66	-1.35
Total Liabilities & Shareholders' Equity	2.17	1.6	1.09	17.7	6.92
Total Common Shares Outstanding